| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.4M | -32.3% |
| Cost of Revenue | $10.1M | -35.2% |
| Gross Profit | $6.3M | -27.0% |
| R&D Expense | $20K | -71.4% |
| SG&A Expense | $3.4M | -11.3% |
| Operating Income | -$5.1M | -15.5% |
| Pre-tax Income | -$4.9M | -26.4% |
| Income Tax | -$1.1M | — |
| Net Income | -$4.9M | -28.3% |
| EPS (Basic) | -$0.39 | -5.4% |
| EPS (Diluted) | -$0.39 | -5.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $857K | -67.5% |
| Inventory | $37K | -5.1% |
| Current Assets | $7.7M | +21.5% |
| Total Assets | $13.0M | -19.0% |
| Current Liabilities | $2.0M | -52.2% |
| Total Liabilities | $2.0M | -65.4% |
| Stockholders' Equity | $11.0M | +7.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $603K | -30.8% |
| Capital Expenditures | $18K | +157.1% |
| Investing Cash Flow | -$2.7M | -375.3% |
| Financing Cash Flow | $3.7M | +694.2% |
| Free Cash Flow | $585K | -32.3% |